glp 1 drugs kidney disease Real-World Evidence for GLP-1 Receptor Agonists Across the CKD Spectrum – AJKD Blog SGLT2 vs GLP-1 for CKD:

Effects of liraglutide versus placebo on cardiovascular events in patients with type 2 diabetes mellitus and chronic kidney disease: results from the LEADER trial

That policy was cemented in the Medicare Prescription Drug, Improvement, and Modernization Act of 2003

For example, medications like ACE inhibitors , ARBs , and beta-blockers generally do not interfere with the cardiovascular benefits of GLP-1 therapies

[DOI] [PubMed] [Google Scholar] 143.Lopez-Ruiz A, del Peso-Gilsanz C, Meoro-Aviles A, Soriano-Palao J, Andreu A, Cabezuelo J, Arias JL

There are still safe, effective options to use

also notes that his craving for sweets is essentially gone